Carmel, IN-based startup Nanovis is no stranger to nabbing research grants. It's just nabbed one from the National Institutes of Health for preclinical research on the use of its porous Forticore interbody fusion devices in combination with nanotube technology. The combination is expected to result in a surface that mimics nature and encourages regeneration around an implant.
The Clinical Center at the National Institutes of Health (NIH) said last month that it would test a photon-counting CT scanner for the first time on humans. This is the first hospital-based research of this sort of device with more than 45 participants enrolled in the trial. The NIH noted that only three sites globally use this sort of technology.
Back in January, a group of congressional representatives urged officials at the National Institutes of Health and the U.S. Department of Health and Human Services (HHS) to take some "extraordinary action" to bring down rising drug prices. HHS has considered the request, and now it has its answer: No.
NIH has rounded up the leading lights of the electronic health records (EHR) sector to address some long-standing shortcomings of their industry. The plan is to adopt open, standardized APIs to enable patients to easily contribute their health data to research programs, a process that is currently made difficult by interoperability limitations.
Verily, Alphabet's life sciences spinoff, has been keeping busy with R&D; the past year. Now the company is adding another project to its load after the National Institutes of Health (NIH) tapped the company to co-launch President Obama's previously announced Precision Medicine Initiative.
Should the NIH scrap its current peer-review model to determine which studies it should bankroll and turn to a more random lottery system? A trio of researchers says yes, pointing to a new study of their own that shows just how hard it can be to judge the best scientific projects among top-tier proposals.
Zika developments continued at an accelerated pace this week with the WHO saying that India's Bharat Biotech and the U.S. National Institutes of Health are farthest along in vaccine development.
Last month, a group of lawmakers urged the National Institutes of Health (NIH) and the U.S. Department of Health and Human Services (HHS) to take "extraordinary" action to fight rising drug prices. HHS got the note and is considering rolling out new guidelines to bring down skyrocketing prices.
Vice President Joe Biden has put improved data sharing at the center of a government-led initiative to cure cancer. The plan is to create conditions that usher improved drugs to market by working with tech companies to pull down data silos while boosting the resources available to public and private research teams.
Leaders at NIH's genomics research wing are planning to funnel $240 million into the Centers for Common Disease Genomics, a newly created group focused on identifying the genetic factors involved in widespread health issues such as heart disease, diabetes, stroke and autism.